Ocular Pharmacology and Therapeutics Conference

眼部药理学和治疗会议

• 批准号: 8837851
• 负责人: W Daniel Stamer
• 金额: $ 2.5万
• 依托单位: DUKE UNIVERSITY
• 依托单位国家: 美国
• 财政年份: 2014
• 资助国家: 美国
• 起止时间: 2014-12-01 至 2015-11-30
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/8837851
• 关键词: Academia; Address; Area; Award; Basic Science; Blood flow; Caring; Clinical Research; Collaborations; Creativeness; Devices; Diagnosis; Disease; Doctor of Philosophy; Drug Delivery Systems; Environment; Ethnic group; Evaluation; Eye; Eye diseases; Feedback; Fellowship; Fostering; Funding; Future; Gene Mutation; Glaucoma; Goals; Immunology; Individual; Industry; International; Ischemia; Knowledge; Lead; Mind; Modification; Nature; Ophthalmologist; Participant; Pharmaceutical Preparations; Pharmacologic Substance; Pharmacology; Recording of previous events; Recruitment Activity; Research; Research Personnel; Resources; Retinal; Scientist; South Carolina; Students; Technology; Therapeutic; Time; Translational Research; Translations; Travel; Underrepresented Minority; Universities; Vision; Vision research; Woman; Work; age effect; base; career; career development; direct application; drug development; drug discovery; educational atmosphere; interest; lectures; meetings; new technology; next generation; novel; novel strategies; novel therapeutic intervention; novel therapeutics; ocular surface; posters; pre-doctoral; processing speed; professor; programs; public health relevance; response; social; symposium; technology development; unpublished works

 DESCRIPTION (provided by applicant): This proposal seeks support for the XII Biennial Conference of the Association for Ocular Pharmacology and Therapeutics (AOPT) to be held February 26th - March 1st, 2015 in Charleston, SC. As with the previous eleven meetings, the goal of AOPT 2015 is to bring together basic scientists, clinicians, students and fellows for presentations and in-depth discussions on new approaches for treating sight-threatening eye diseases. Selection of each of the scientific sessions was based on identification of those ocular fields making important advances that will lead to new therapeutics. We have recruited experts and leaders in these respective areas to chair and program these scientific sessions. In addition to a keynote lecture by Professor Palczewski, we identified ten exciting topics for inclusion in our conference. Additionally, a specific goal of the conference is to increase student and junior investigator participation with travel awards and a featured 11th platform session for young scientists. AOPT has an established history for promoting diversity, and the speakers that are selected represent a diverse group of scientists including women and underrepresented individuals. The Specific Aims of the XII Association for Ocular Pharmacology and Therapeutics Conference are: 1. to enhance the emerging careers of 20 young investigators (including women and underrepresented minorities) in ocular therapeutics by providing travel awards. 2. To provide a forum for dissemination of the most recent advances in the state of knowledge on novel therapeutic approaches to ocular disorders and disease. 3. To create an environment that will facilitate the exchange of novel ideas among basic and clinician scientists and generate the opportunity for vision scientists of all ethnic groups and social backgrounds to meet and establish research collaborations. 4. To bring together scientists working in academia and industry with the goal of expediting the delivery of novel therapeutics to those suffering from ocular diseases or disorders. We anticipate that this meeting will provide useful information on recent advances in ocular diseases and will serve as an important resource for those involved in the translation of these findings into suitable therapeutics. This conference will also provide new opportunities, avenues for new discovery, and a forum to develop potential collaborations among the attendees. The requested funds will support the travel, accommodation and registration of 10 students (pre- and postdoctoral) and 10 junior investigators who otherwise would not have the resources to attend this focused meeting.

 描述（申请人提供）：本提案寻求对将于2015年2月26日至3月1日在南卡罗来纳州查尔斯顿举行的第十二届眼科药理学和治疗学协会（AOPT）两年一度会议的支持。与前十一届会议一样，2015年AOPT的目标是汇集基础科学家、临床医生、学生和研究员就治疗威胁视力的眼病的新方法进行演讲和深入讨论。每一次科学会议的选择都是基于对那些取得重要进展的眼部领域的识别，这些进展将导致新的治疗方法。我们已经招募了这些领域的专家和领导人来主持和安排这些科学会议。除了Palczewski教授的主题演讲外，我们还确定了十个令人兴奋的主题，供我们的会议讨论。此外，会议的一个具体目标是增加学生和初级研究人员的参与，并为年轻科学家提供旅行奖励和第11届特色平台会议。AOPT在促进多样性方面有着悠久的历史，被选中的演讲者代表了包括妇女和代表性不足的个人在内的各种科学家群体。第十二届眼科药理学和治疗学会议的具体目标是：1。通过提供旅行奖励，促进20名年轻研究人员（包括妇女和代表性不足的少数民族）在眼科治疗方面的新兴职业发展。2.提供一个论坛，传播眼部疾病和疾病的新治疗方法的最新知识进展。3.创造一个环境，促进基础和临床科学家之间的新思想的交流，并为所有种族和社会背景的视觉科学家创造机会，以满足和建立研究合作。4.将学术界和工业界的科学家聚集在一起，以加快向患有眼部疾病或疾病的人提供新疗法的目标。我们预计，这次会议将提供有用的信息，在眼科疾病的最新进展，并将作为一个重要的资源，为那些参与翻译这些发现到合适的治疗。本次会议还将提供新的 机会，新发现的途径，以及一个论坛，以发展与会者之间的潜在合作。所要求的资金将用于10名学生（博士前和博士后）和10名初级研究人员的差旅、住宿和注册，否则他们将没有资源参加这次重点会议。